Literature DB >> 5862422

The structure of the glucuronide of sulphadimethoxine formed in man.

J W Bridges, M R Kibby, R T Williams.   

Abstract

1. The major metabolite of 2,4-dimethoxy-6-sulphanilamidopyrimidine (sulphadimethoxine) in urine in man is a non-reducing glucuronide, which has been isolated and characterized as its S-benzylthiouronium salt. 2. The same compound was made synthetically by standard methods from sodium sulphadimethoxine and methyl 2,3,4-tri-O-acetyl-1-bromoglucuronate. 3. On hydrolysis with acid, the glucuronide yielded sulphanilic acid, glucuronic acid and barbituric acid, and with beta-glucuronidase it slowly yielded sulphadimethoxine and glucuronic acid. 4. Evidence based on infrared spectra and other data showed that the urinary and synthetic glucuronide was 1-deoxy-1-[N(1)'-(2'',4''-dimethoxypyrimidin-6'' -yl)sulphanilamido-beta-d-glucosid]uronic acid or sulphadimethoxine N(1)-glucuronide. 5. N(1)-Methyl- and N(ring)-methyl derivatives of sulphadimethoxine and 4-methoxy-6-sulphanilamidopyrimidine were prepared and their infrared and ultraviolet spectra determined for comparison.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5862422      PMCID: PMC1207225          DOI: 10.1042/bj0960829

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  INFRARED SPECTRA OF SULFONAMIDE DERIVATIVES. I. PYRIDINE, THIAZOLE, AND PYRIMIDINE DERIVATIVES.

Authors:  T UNO; K MACHIDA; K HANAI; M UEDA; S SASAKI
Journal:  Chem Pharm Bull (Tokyo)       Date:  1963-06       Impact factor: 1.645

2.  METABOLISM OF DRUGS. XXXIX. FURTHER STUDIES ON CARBAMATE N-GLUCURONIDE FORMATION IN ANIMAL BODY.

Authors:  H TSUKAMOTO; H YOSHIMURA; K TATSUMI
Journal:  Chem Pharm Bull (Tokyo)       Date:  1963-09       Impact factor: 1.645

3.  [The results of bacteriological testing of two new sulfonamides].

Authors:  E SEMENITZ
Journal:  Z Immun exp ther       Date:  1954-11

4.  Further studies on carbamate N-glucuronide formation in animal body.

Authors:  H TSUKAMOTO; H YOSHIMURA; K TATSUMI
Journal:  Life Sci (1962)       Date:  1963-06

5.  [Studies on the metabolism of sulfisoxazole. VI. On the new metabolite of sulfisoxazole in human].

Authors:  T UNO; M KONO
Journal:  Yakugaku Zasshi       Date:  1962-12       Impact factor: 0.302

6.  Toxicologic and metabolic studies on 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).

Authors:  L O RANDALL; R E BAGDON; R ENGELBERG
Journal:  Toxicol Appl Pharmacol       Date:  1959-01       Impact factor: 4.219

7.  Metabolic N- and O-demethylation of morphine- and morphinan-type analgesics.

Authors:  A E TAKEMORI; G J MANNERING
Journal:  J Pharmacol Exp Ther       Date:  1958-07       Impact factor: 4.030

8.  The preparation and properties of beta-glucuronidase. IV. Inhibition by sugar acids and their lactones.

Authors:  G A LEVVY
Journal:  Biochem J       Date:  1952-11       Impact factor: 3.857

9.  Chemotherapeutic studies with 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).

Authors:  R J SCHNITZER; W F DELORENZO; E GRUNBERG; R RUSSOMANNO
Journal:  Proc Soc Exp Biol Med       Date:  1958-11

10.  Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen.

Authors:  B B BRODIE; J AXELROD; P A SHORE; S UDENFRIEND
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

  10 in total
  21 in total

1.  Two-stage penetration of a single oral dose of sulphadimethoxine into skin blister fluid.

Authors:  A Nowak; A Klimowicz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The comparison of some pharmacokinetic parameters of sulphadimethoxine estimated by high performance liquid chromatography and three spectrophotometric methods.

Authors:  A Klimowicz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

3.  The metabolism of cyclohexanecarboxylate in the rat.

Authors:  D Brewster; R S Jones; D V Parke
Journal:  Biochem J       Date:  1977-06-15       Impact factor: 3.857

4.  Metabolites of sulphadimethoxypyrimidine in the urine of various species.

Authors:  S R Walker; R T Williams
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

5.  Disposition of [4-14C]mofebutazone in the rat.

Authors:  V M Bass; R I Mrongovius; K E Schulte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

6.  Covalent binding and glutathione depletion in the rat following niridazole (ambilhar) pretreatment.

Authors:  I N Oduah; M I Thabrew; G O Emerole
Journal:  Arch Toxicol       Date:  1985-04       Impact factor: 5.153

7.  N1-glucosides as urinary metabolites of sulphadimidine, sulphamerazine and sulphamethoxazole.

Authors:  B Ahmad; J W Powell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jul-Sep       Impact factor: 2.441

8.  Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man.

Authors:  T B Vree; E W Beneken Kolmer; M Martea; R Bosch; Y A Hekster; M Shimoda
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

9.  Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria.

Authors:  R H Adamson; J W Bridges; M E Evans; R T Williams
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

10.  The metabolic fate of amphetamine in man and other species.

Authors:  L G Dring; R L Smith; R T Williams
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.